(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease, the Danish drugmaker said on Tuesday.

In the UK, patients can buy a four-week supply of Ozempic for between £119 and £190 from online pharmacies. Novo Nordisk said it has no plans to rise UK prices, despite pressure from Trump.

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes. Between 30 and 50 per cent of people with Type 2 diabetes develop some form of chronic kidney disease.

Ozempic, the viral weight-loss injection, is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, vision loss, and lasting health damage

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo Nordisk, the maker of the GLP-1 drug Ozempic, announced Monday that U.S. patients can now get a month’s supply for just under $500. It typically carries a list price of around $1,000 a month.

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and eyes. Learn the signs and symptoms.

Reports are emerging of women experiencing changes in their genital area, dubbed 'Ozempic vulva,' linked to rapid weight loss from drugs like Ozempic.

A woman who said she got 'Ozempic vulva' explained what getting the side effect of rapid weight loss was really like. The number of people taking drugs for weight loss has absolutely boomed in recent years, and while Ozempic is the one everyone knows, it's not actually what you could be prescribed to lose weight.